Ocuphire Pharma Plunges Following CEO Termination, New Appointment: The Bull, Bear Case

The massive downturn in Ocuphire caused the stock to negate an uptrend it had been trading in since April 3, when it broke up from a long period of sideways consolidation.

An uptrend occurs when a stock consistently makes a series of higher highs and higher lows on the chart.

The higher highs indicate the bulls are in control while the intermittent higher lows indicate consolidation periods.

Want direct analysis? Find me in the BZ Pro lounge! Click here for a free trial.

The Ocuphire Chart: Ocuphire negated its downtrend by making a lower low under the April 14 higher low of $5.01. For a new downtrend to confirm, Ocuphire will need to eventually bounce up to print a lower high under $6.50.

Read Next: Actinium Announces Positive Phase 3 Trial Results, NCI CRADA For AML Drug Candidates – Could They Become New Standards Of Care For This Deadly Disease?

Photo: Shutterstock

 

Market News and Data brought to you by Benzinga APIs

To add Benzinga News as your preferred source on Google, click here.